Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation TCT 2023

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

Presenter: Sanjit Jolly

October 25, 2023

Presentation TCT 2023

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

Presenter: Taehoon Kim

October 25, 2023

Presentation TCT 2023

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

Presenter: Hyunki LEE

October 25, 2023

Presentation TCT 2023

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

Presenter: Sanjit Jolly

October 25, 2023

Presentation TCT 2023

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Presenter: Stefan Verheye

October 25, 2023

Presentation TVT 2023

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Presenter: Mustafa Suppah

June 08, 2023

Presentation TVT 2023

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Presenter: Olayiwola Bolaji

June 08, 2023

Advertisement

Keynote Lecture: Which Anticoagulant or Antiplatelet Regimen Post LAAO - The Present and Future?

TCT 99: Efficacy and safety of early single direct oral anticoagulant therapy within one year after coronary stent implantation in patients with atrial fibrillation

TCT 657: Aspirin versus P2Y12 inhibitor as a combination therapy with direct oral anticoagulant after coronary stent implantation in patients with atrial fibrillation (AF).

STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Atrial Fibrillation Patients With Bioprosthetic Valves: A Systematic Review, Meta-Analysis and Network Meta-Analysis

Comparative Effectiveness of Left Atrial Appendage Closure and Direct Oral Anticoagulants in Atrial Fibrillation Patients: A Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content